Literature DB >> 10440745

Expression of the laminin gamma2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization.

M Määttä1, Y Soini, P Pääkkö, S Salo, K Tryggvason, H Autio-Harmainen.   

Abstract

Sixty-four malignant lung tumours and 12 of their regional lymph node metastases were analysed for expression of the laminin gamma2 chain by immunohistochemistry and in situ hybridization. Expression of the laminin gamma2 chain was strongest in squamous cell carcinomas, followed by adenocarcinomas and large cell carcinomas. Positive cells, except for large cell carcinomas, were located at the epithelial-stromal interface of tumour clusters. An important exception was small cell lung carcinoma, with only a low level of laminin gamma2 chain expression. Apart from tumour type, this may reflect the relatively scanty fibrous stroma in these tumours and supports previous observations that small cell lung carcinoma cells, contrary to other types, lack surface expression of alpha(6)beta(4) integrin, the specific laminin-5 binding receptor. In frozen sections, immunohistochemistry showed linear basement membranes around tumour clusters in squamous cell carcinomas and adenocarcinomas. This shows that carcinoma cells are capable of heavy deposition of the laminin gamma2 chain around tumour clusters and suggests that a laminin gamma2 chain-containing substrate may be of significance for the spread and growth of malignant tumours. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440745     DOI: 10.1002/(SICI)1096-9896(199908)188:4<361::AID-PATH363>3.0.CO;2-0

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  20 in total

1.  Distribution of basement membrane anchoring molecules in normal and transformed endometrium: altered expression of laminin gamma2 chain and collagen type XVII in endometrial adenocarcinomas.

Authors:  Marko Määttä; Sirpa Salo; Kaisa Tasanen; Ylermi Soini; Annikki Liakka; Leena Bruckner-Tuderman; Helena Autio-Harmainen
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

Review 2.  Bridging structure with function: structural, regulatory, and developmental role of laminins.

Authors:  Julia Tzu; M Peter Marinkovich
Journal:  Int J Biochem Cell Biol       Date:  2007-08-06       Impact factor: 5.085

3.  MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas.

Authors:  Jason H Gill; Ian G Kirwan; Jill M Seargent; Sandie W Martin; Sidiq Tijani; Vladimir A Anikin; Alan J Mearns; Michael C Bibby; Alan Anthoney; Paul M Loadman
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

4.  Investigation into the mechanism of the loss of laminin 5 (alpha3beta3gamma2) expression in prostate cancer.

Authors:  J Hao; L Jackson; R Calaluce; K McDaniel; B L Dalkin; R B Nagle
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  LAMC2 enhances the metastatic potential of lung adenocarcinoma.

Authors:  Y W Moon; G Rao; J J Kim; H-S Shim; K-S Park; S S An; B Kim; P S Steeg; S Sarfaraz; L Changwoo Lee; Donna Voeller; E Y Choi; Ji Luo; D Palmieri; H C Chung; J-H Kim; Y Wang; G Giaccone
Journal:  Cell Death Differ       Date:  2015-01-16       Impact factor: 15.828

Review 6.  Laminin-5 in epithelial tumour invasion.

Authors:  Masahiko Katayama; Kiyotoshi Sekiguchi
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

Review 7.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

8.  Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis.

Authors:  Heidi Kuula; Tuula Salo; Emma Pirilä; Anita M Tuomainen; Matti Jauhiainen; Veli-Jukka Uitto; Leo Tjäderhane; Pirkko J Pussinen; Timo Sorsa
Journal:  Infect Immun       Date:  2008-11-24       Impact factor: 3.441

9.  Contribution of MT1-MMP and of human laminin-5 gamma2 chain degradation to mammary epithelial cell migration.

Authors:  C Gilles; M Polette; C Coraux; J M Tournier; G Meneguzzi; C Munaut; L Volders; P Rousselle; P Birembaut; J M Foidart
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

10.  Laminin-5 is a biomarker of invasiveness in cervical adenocarcinoma.

Authors:  Johji Imura; Yoshiaki Uchida; Kazuhiro Nomoto; Kazuhito Ichikawa; Shigeki Tomita; Tatsuo Iijima; Takahiro Fujimori
Journal:  Diagn Pathol       Date:  2012-08-17       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.